HIV treatment bulletin

RSS Atom • ISSN 1472-4683 • Subscribe • About

11th Conference on Retrovirus and Opportunistic Infections, 8-11 February 2004, San Francisco

• 11th Conference on Retroviruses and Opportunistic Infections (CROI), 8-11 February 2004, San Francisco Conference reports - Conference index - CROI 11 (Retrovirus) 2004 - 2 May 2004

• HIV-associated dementia and cognitive dysfunction Conference reports - Opportunistic infections and complications - CROI 11 (Retrovirus) 2004 - 2 May 2004

• Diabetes and HIV and HCV; aging/HIV and diabetes Conference reports - Lipodystrophy and metabolic complications - Side effects - CROI 11 (Retrovirus) 2004 - 2 May 2004

• Treatment with generics: tolerability, safety and resistance Antiretrovirals - Treatment access - CROI 11 (Retrovirus) 2004 - 5 April 2004

• 11th Conference on Retroviruses and Opportunistic Infections (CROI) Conference reports - Conference index - CROI 11 (Retrovirus) 2004 - 3 April 2004

• Drug levels can persist for more than two weeks after stopping efavirenz Antiretrovirals - Conference reports - PK and drug interactions - CROI 11 (Retrovirus) 2004 - 3 April 2004

• Race affects absorption and clearance of efavirenz Conference reports - PK and drug interactions - Side effects - CROI 11 (Retrovirus) 2004 - 3 April 2004

• Triple PI interactions: atazanavir increases saquinavir levels in ritonavir-boosted once-daily combination Conference reports - PK and drug interactions - CROI 11 (Retrovirus) 2004 - 3 April 2004

• Triple PI interactions: fosamprenavir and Kaletra interaction is difficult to overcome Conference reports - PK and drug interactions - CROI 11 (Retrovirus) 2004 - 3 April 2004

• Ribavirin (RBV) does not alter intracellular levels of AZT, 3TC or d4T Conference reports - Hepatitis coinfection - PK and drug interactions - CROI 11 (Retrovirus) 2004 - 3 April 2004

• COLATE study shows no clinical benefit from continuing 3TC to maintain M184V mutation Antiretrovirals - Conference reports - CROI 11 (Retrovirus) 2004 - 3 April 2004

• Studies of new pipeline drugs Antiretrovirals - Conference reports - CROI 11 (Retrovirus) 2004 - 3 April 2004

• Little benefit seen for treatment during acute infection Antiretrovirals - Basic science and immunology - Conference reports - CROI 11 (Retrovirus) 2004 - 3 April 2004

• Summary of resistance studies at Retrovirus Conference reports - Resistance - CROI 11 (Retrovirus) 2004 - 3 April 2004

• Update on peripheral neuropathy in HIV-infection Conference reports - Side effects - CROI 11 (Retrovirus) 2004 - 3 April 2004

• Smoking marijuana provides analgesic effect on HIV neuropathy Conference reports - Side effects - CROI 11 (Retrovirus) 2004 - 3 April 2004

• Two D:A:D updates: cardiovascular risk from HAART, and predictors of hypertension and changes in blood pressure Conference reports - Side effects - CROI 11 (Retrovirus) 2004 - 3 April 2004

• Low-dose rHGH maintains reductions in abdominal fat for 60 weeks Conference reports - Lipodystrophy and metabolic complications - Side effects - CROI 11 (Retrovirus) 2004 - 3 April 2004

• Rosiglitazone shows no benefit for lipoatrophy Conference reports - Lipodystrophy and metabolic complications - Side effects - CROI 11 (Retrovirus) 2004 - 2 April 2004

• Hypertension related to HAART in HIV-positive women Conference reports - Women's health - CROI 11 (Retrovirus) 2004 - 2 April 2004

• Testosterone therapy for women with low androgen levels or body weight Conference reports - Women's health - CROI 11 (Retrovirus) 2004 - 2 April 2004

• Nevirapine, pregnancy and adverse events Conference reports - PMTCT and maternal health - CROI 11 (Retrovirus) 2004 - 2 April 2004

• Prior nevirapine exposure for pregnant women can contribute to treatment failure Conference reports - CROI 11 (Retrovirus) 2004 - 2 April 2004

• Conflicting findings with HAART use in pregnancy and prematurity Conference reports - PMTCT and maternal health - CROI 11 (Retrovirus) 2004 - 2 April 2004

• Antiretrovirals, mode of delivery and transmission risk Conference reports - PMTCT and maternal health - CROI 11 (Retrovirus) 2004 - 2 April 2004

• Tenofovir studies in children Conference reports - Paediatric care - CROI 11 (Retrovirus) 2004 - 2 April 2004

• Increase of non-AIDS defining cancers in HOPS cohort Cancer and HIV - Conference reports - CROI 11 (Retrovirus) 2004 - 2 April 2004

• HIV/HCV coinfection: superiority of pegylated interferon plus ribavirin, but lower response rate compared to mono-infected patients, especially for genotype-1 Conference reports - Hepatitis coinfection - CROI 11 (Retrovirus) 2004 - 2 April 2004

• Epoetin-alfa improves interferon/ribavirin-associated anaemia Conference reports - Hepatitis coinfection - CROI 11 (Retrovirus) 2004 - 2 April 2004